Dr. Scott Lick, MD

Cardiac Surgery  ·  
Male  ·  
Age 57
Insurances Accepted  ·  Save
Dr. Scott Lick, MD
"Scott D. Lick, MD, is a professor of surgery at the University of Arizona College of Medicine – Tucson, and director of Heart and Lung Transplant Surgery at the Arizona Medical Center. Dr. Lick has 20 years experience in all aspects of cardiac surgery and heart and lung transplantation. He is an active researcher, studying artificial lung development. He has more than 90 peer-reviewed scientific articles and abstracts and is committed to the innovation and discovery necessary for the next decade of advances in cardiac surgery, as well as heart and lung transplantation. Dr. Lick was previously a professor of surgery and director of Thoracic Organ Transplantation at the The University of Texas Medical Branch in Galveston. As a resident, Dr. Lick worked with Jack Copeland, MD, former chief of the Division of Cardiothoracic Surgery, who is recognized for performing the world’s first successful bridge to heart transplant with a total artificial heart. A fellow in the American College of Surgeons, Dr. Lick has been named one of the “Best Doctors in America” every year since 1999, and one of Texas Monthly’s “Texas Super Doctors” in 2004 and 2010, 2011, 2012 and 2013."

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

301 UNIVERSITY BLVD

Galveston, TX 77555

Contact Information

(409) 772-1203

Dr. Scott Lick, MD

Dr. Scott Lick, MD

Accepted insurance

  • Aetna
  • Blue Cross Blue Shield
  • Blue Cross Blue Shield of Texas
  • Cigna
  • First Health (Coventry Health Care)
  • MultiPlan

*Please verify this information when scheduling an appointment.

Learn about Dr. Lick

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Top Care Areas

See how frequently Dr. Lick performs your care needs compared to other doctors.

Vascular Disease
normal
more than 60% of peers
Pulmonary Disease
normal
more than 39% of peers
Pleural Effusion
normal
more than 34% of peers

Dr. Lick's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

Dr. Lick's bio

This content was provided by Dr. Lick "Scott D. Lick, MD, is a professor of surgery at the University of Arizona College of Medicine – Tucson, and director of Heart and Lung Transplant Surgery at the Arizona Medical Center. Dr. Lick has 20 years experience in all aspects of cardiac surgery and heart and lung transplantation. He is an active researcher, studying artificial lung development. He has more than 90 peer-reviewed scientific articles and abstracts and is committed to the innovation and discovery necessary for the next decade of advances in cardiac surgery, as well as heart and lung transplantation. Dr. Lick was previously a professor of surgery and director of Thoracic Organ Transplantation at the The University of Texas Medical Branch in Galveston. As a resident, Dr. Lick worked with Jack Copeland, MD, former chief of the Division of Cardiothoracic Surgery, who is recognized for performing the world’s first successful bridge to heart transplant with a total artificial heart. A fellow in the American College of Surgeons, Dr. Lick has been named one of the “Best Doctors in America” every year since 1999, and one of Texas Monthly’s “Texas Super Doctors” in 2004 and 2010, 2011, 2012 and 2013."
Less
Read Less

1  Specialties

  • Cardiac Surgery

2  Board Certifications

  • General Surgery
    Accredited by: American Board of Surgery*
  • Thoracic Cardiovascular Surgery
    Accredited by: American Board of Thoracic Surgery*

38  Conditions Treated

Less
Read Less

29  Procedures

  • Abscess or Cyst Drainage or Aspiration
  • Abscess or Fluid Incision and Drainage
  • Arteriovenous Shunt Creation
  • Colectomy
  • Colon and Rectal Surgery
  • Dialysis Access Procedures
  • Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
  • Esophageal Surgery
  • Excision of Skin Lesion
  • Gallbladder Removal
  • Gallbladder Removal (Cholecystectomy), Open
  • Gastroenterology Procedures
  • Head and Neck Surgery
  • Heart Surgery
  • Hernia Repair
  • Incision and Removal of Foreign Object
  • Intestinal Transplant (incl. Enterectomy)
  • Kidney Surgery
  • Laparoscopic Surgical Procedure
  • Laparotomy
  • Lung Surgery
  • Lymph Node Biopsy or Excision
  • Peripheral Artery Catheterization
  • Port Placements or Replacements
  • Thoracentesis
  • Tracheal Surgery
  • Umbilical or Ventral Hernia Repair, Laparoscopic
  • Vascular Surgical Procedure
  • Video-Assisted Thoracoscopic Surgery (VATS) or Thoracotomy

Background Check

0 Malpractice Claims

No malpractice history found for Texas.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • University Of Minnesota Medical School
    Medical School | Graduated 1987
  • University Ariz College Med
    Internship Hospital | Completed 1988
  • University Ariz College Med
    Residency Hospital | Completed 1992

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
Media & Publications

Dr. Lick has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Lick does not have any memberships or affiliations listed. If you are Dr. Lick and would like to add memberships or affiliations, please update your profile.

Dr. Lick's Reviews

Help millions of people find the right doctor. Share your experience today!
Likelihood of recommending Dr. Lick to family and friends
Image of Dr. Lick
Are you Dr. Lick?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Visit Dr. Lick

Now Accepting New Patients
This provider offers the following appointment availability:
Same Day
Next Day

Dr. Lick accepts 6 insurance carriers

  • Aetna
    Aetna HMO
    Choice Plus POS II
  • Blue Cross Blue Shield
    Blue Card PPO
  • Blue Cross Blue Shield of Texas
    Blue Advantage HMO
    Blue Choice
  • Cigna
    Cigna HMO
    Cigna PPO
    Open Access Plus
  • First Health (Coventry Health Care)
    First Health (Coventry Health Care) PPO
  • MultiPlan
    MultiPlan PPO
    PHCS Network PPO
Less
Read Less

*Please verify this information when scheduling an appointment.

Dr. Lick's affiliated hospitals

Banner Children's - Diamond Children's Medical Center
1501 North Campbell Avenue
Tucson, AZ 85724
View hospital profile

Nearby doctors with similar experience

Cardiac Surgery
(41)
Cardiac Surgery
(40)
Cardiac Surgery
(81)
Cardiac Surgery
(2)
Cardiac Surgery
(14)
Cardiac Surgery
(20)
Interventional Cardiology
(19)
Cardiac Surgery
(38)
Cardiac Surgery
(35)